Wondfo

Guangzhou Wondfo Biotech Co., Ltd. specializes in the research, development, manufacturing, sales, and service of in vitro diagnostic (IVD) and point-of-care testing (POCT) solutions. The company provides diagnostic products and technologies for applications including infectious diseases, cardiovascular diseases, diabetes, renal function, respiratory diseases, fertility, tumors, and drug-of-abuse testing.

Wondfo develops solutions across multiple technology platforms, including immunofluorescence, chemiluminescence, molecular diagnostics, coagulation, blood gas analysis, pathology, HPLC hemoglobin analysis, and colloidal gold-based testing. Its portfolio includes diagnostic instruments, reagents, consumables, and related solutions for clinical and point-of-care applications.